Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5611625 | Journal of the American Society of Echocardiography | 2008 | 7 Pages |
Abstract
The combination of a newer quantitative echocardiographic technique (SR analysis) and a newer pharmacologic agent (levosimendan) improves the sensitivity of viability assessment compared with conventional dobutamine echocardiography.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Cinzia MD, Francesco MD, Vincenzo MD, PhD, Antonio MD, Vincenzo MD, Giuseppe MD, Massimo MD,